CIK: 1620137 - Address: C/O Kiora Pharmaceuticals, Inc., 1371 E. 2100 South, Suite 200, Waltham, MA 02452
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111137151964024
P%wins100100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

7/15/19 20:37
7/11/19
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsFrom StephenMADOP,CEOS.m-300.23640-127-111,032D
4/18/18 17:23
4/17/18
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsFrom StephenMADOP,CEOP.d00.00012544410D
8/10/17 17:57
8/10/17
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsFrom StephenMADOP,CEOP131.030135272D
6/14/17 16:50
6/14/17
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsFrom StephenMADOP,CEOP.d00.0006030260D
9/16/16 16:15
9/15/16
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsFrom StephenMADOP,CEOP221.4901512140D-62-55-54-31-16-16-11137151964
7/5/16 16:11
6/30/16
EYEGEyegate Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsFrom StephenMADOP,CEOM.d340.647805374125D-36-7-14-18-16-16-1-5-4-20-33-37

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact